磷酸化蛋白激酶B抗体Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase.磷酸化蛋白激酶B抗体 In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]
磷酸化蛋白激酶B抗体Also known as:
AKT1 (phospho S129); p-AKT1 (phospho S129); AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1;磷酸化蛋白激酶B抗体 vAKT Murine Thymoma Viral Oncogene Homolog 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Horse, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Akt1 around the phosphorylation site of Ser129.
●
磷酸化蛋白激酶B抗体Predicted Molecular Weight: 56kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl431Po01颗粒酶M(GZMM)多克隆抗体Polyclonal Antibody to Granzyme M (GZMM)
kl431Ra01颗粒酶M(GZMM)多克隆抗体Polyclonal Antibody to Granzyme M (GZMM)
kl435Hu01热休克转录因子1(HSF1)多克隆抗体Polyclonal Antibody to Heat Shock Transcription Factor 1 (HSF1)
kl435Ra01热休克转录因子1(HSF1)多克隆抗体Polyclonal Antibody to Heat Shock Transcription Factor 1 (HSF1)
kl437Hu01雌激素受体β(ERβ)多克隆抗体Polyclonal Antibody to Estrogen Receptor Beta (ERb)
kl437Ra01雌激素受体β(ERβ)多克隆抗体Polyclonal Antibody to Estrogen Receptor Beta (ERb)
kl439Hu01蛋白激酶Cε(PKCε)多克隆抗体Polyclonal Antibody to Protein Kinase C Epsilon (PKCe)
kl439Mu01蛋白激酶Cε(PKCε)多克隆抗体Polyclonal Antibody to Protein Kinase C Epsilon (PKCe)
kl442Hu01阻抑素(PHB)多克隆抗体Polyclonal Antibody to Prohibitin (PHB)
kl442Mu01阻抑素(PHB)多克隆抗体Polyclonal Antibody to Prohibitin (PHB)
kl442Ra01阻抑素(PHB)多克隆抗体Polyclonal Antibody to Prohibitin (PHB)
kl444Hu01桥粒芯糖蛋白3(DSG3)多克隆抗体Polyclonal Antibody to Desmoglein 3 (DSG3)
kl446Hu01抑制素βC(INHβC)多克隆抗体Polyclonal Antibody to Inhibin Beta C (INHbC)
kl446Ra01抑制素βC(INHβC)多克隆抗体Polyclonal Antibody to Inhibin Beta C (INHbC)
kl449Hu01胱天蛋白酶7(CASP7)多克隆抗体Polyclonal Antibody to Caskle 7 (CASP7)
kl449Mu01胱天蛋白酶7(CASP7)多克隆抗体Polyclonal Antibody to Caskle 7 (CASP7)
kl449Ra01胱天蛋白酶7(CASP7)多克隆抗体Polyclonal Antibody to Caskle 7 (CASP7)
kl450Hu01激肽释放酶4(KLK4)多克隆抗体Polyclonal Antibody to Kallikrein 4 (KLK4)
kl450Mu01激肽释放酶4(KLK4)多克隆抗体Polyclonal Antibody to Kallikrein 4 (KLK4)
kl450Ra01激肽释放酶4(KLK4)多克隆抗体Polyclonal Antibody to Kallikrein 4 (KLK4)
kl451Hu01激肽释放酶5(KLK5)多克隆抗体Polyclonal Antibody to Kallikrein 5 (KLK5)
kl451Mu01激肽释放酶5(KLK5)多克隆抗体Polyclonal Antibody to Kallikrein 5 (KLK5)
kl457Hu01胱天蛋白酶14(CASP14)多克隆抗体Polyclonal Antibody to Caskle 14 (CASP14)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话